Not applicableStudy completedNCT01600885What this trial is testingThe Effects of Ketamine and Guanfacine on Working Memory in Healthy SubjectsWho this might be right forNMDA Receptor Function Yale University 16
Testing effectiveness (Phase 2)Ended earlyNCT01844726What this trial is testingEffects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric IllnessWho this might be right forPsychiatric IllnessHealthy Northwestern University 44
Testing effectiveness (Phase 2)Study completedNCT01047592What this trial is testingTreatment of N-methyl-D-aspartate (NMDA) Enhancers for SchizophreniaWho this might be right forSchizophrenia Chang-Hua Hospital 63
Not applicableStudy completedNCT03062150What this trial is testingMineralocorticoid Receptor, NMDA Receptor and Cognitive Function in DepressionWho this might be right forMajor Depression Charite University, Berlin, Germany 232
Not applicableStudy completedNCT06023160What this trial is testingPredicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at DiagnosisWho this might be right forAnti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis Erasmus Medical Center 714
Not applicableLooking for participantsNCT05280600What this trial is testingDeveloping Advanced Neuroimaging for Clinical Evaluation of Autoimmune EncephalitisWho this might be right forAnti-N-Methyl-D-Aspartate Receptor EncephalitisAutoimmune Encephalitis King's College London 75
Early research (Phase 1)Study completedNCT00526968What this trial is testingThe Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain FunctionWho this might be right forHuman Volunteers Evotec Neurosciences GmbH 19
Testing effectiveness (Phase 2)Study completedNCT00338598What this trial is testingFacilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid AlcoholismWho this might be right forAlcoholismSchizophrenia Yale University 20